| Rebecca Weiss, | |
|
1370 Old Freeport Rd Ste 2b, Pittsburgh, PA 15238-4104 | |
| (412) 999-4100 | |
| Not Available |
| Full Name | Rebecca Weiss |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 23 Years |
| Location | 1370 Old Freeport Rd Ste 2b, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023247830 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | CW015587 (Pennsylvania) | Primary |
| Entity Name | Upmc Presbyterian Shadyside |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821007881 PECOS PAC ID: 3870401847 Enrollment ID: O20031124000048 |
News Archive
Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.
University of Michigan Health System researchers will use a $3.5 million federal grant to study a new approach in halting the downward spiral of diabetes.
About 70 percent of our genes provide the blueprint for biomolecules whose function is only now being discovered - non-coding RNAs. Instead of being translated into proteins, they seem to perform steering functions in the body.
ADVENTRX Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate ANX-530 (vinorelbine injectable emulsion).
GlaxoSmithKline today confirmed that it will implement a new system for evaluating and compensating its sales professionals beginning in 2011.Under the new system, bonuses for sales professionals who work directly with healthcare professionals and other customers will no longer be based on individual achievement of sales targets, but will be based primarily on the service they deliver to customers. Bonuses will be determined, in part, by customer feedback, and by a sales professional's adherence to the company values of transparency, integrity, respect and patient-focus.
› Verified 6 days ago
| Entity Name | Vista Behavioral Health Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043261480 PECOS PAC ID: 8123920907 Enrollment ID: O20040122000683 |
News Archive
Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.
University of Michigan Health System researchers will use a $3.5 million federal grant to study a new approach in halting the downward spiral of diabetes.
About 70 percent of our genes provide the blueprint for biomolecules whose function is only now being discovered - non-coding RNAs. Instead of being translated into proteins, they seem to perform steering functions in the body.
ADVENTRX Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate ANX-530 (vinorelbine injectable emulsion).
GlaxoSmithKline today confirmed that it will implement a new system for evaluating and compensating its sales professionals beginning in 2011.Under the new system, bonuses for sales professionals who work directly with healthcare professionals and other customers will no longer be based on individual achievement of sales targets, but will be based primarily on the service they deliver to customers. Bonuses will be determined, in part, by customer feedback, and by a sales professional's adherence to the company values of transparency, integrity, respect and patient-focus.
› Verified 6 days ago
| Entity Name | Upmc Advanced Practice Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457769176 PECOS PAC ID: 4082836283 Enrollment ID: O20141103001512 |
News Archive
Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.
University of Michigan Health System researchers will use a $3.5 million federal grant to study a new approach in halting the downward spiral of diabetes.
About 70 percent of our genes provide the blueprint for biomolecules whose function is only now being discovered - non-coding RNAs. Instead of being translated into proteins, they seem to perform steering functions in the body.
ADVENTRX Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate ANX-530 (vinorelbine injectable emulsion).
GlaxoSmithKline today confirmed that it will implement a new system for evaluating and compensating its sales professionals beginning in 2011.Under the new system, bonuses for sales professionals who work directly with healthcare professionals and other customers will no longer be based on individual achievement of sales targets, but will be based primarily on the service they deliver to customers. Bonuses will be determined, in part, by customer feedback, and by a sales professional's adherence to the company values of transparency, integrity, respect and patient-focus.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Weiss, 314 Leblanc St, Pittsburgh, PA 15218-1011 Ph: (412) 999-4100 | Rebecca Weiss, 1370 Old Freeport Rd Ste 2b, Pittsburgh, PA 15238-4104 Ph: (412) 999-4100 |
News Archive
Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.
University of Michigan Health System researchers will use a $3.5 million federal grant to study a new approach in halting the downward spiral of diabetes.
About 70 percent of our genes provide the blueprint for biomolecules whose function is only now being discovered - non-coding RNAs. Instead of being translated into proteins, they seem to perform steering functions in the body.
ADVENTRX Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate ANX-530 (vinorelbine injectable emulsion).
GlaxoSmithKline today confirmed that it will implement a new system for evaluating and compensating its sales professionals beginning in 2011.Under the new system, bonuses for sales professionals who work directly with healthcare professionals and other customers will no longer be based on individual achievement of sales targets, but will be based primarily on the service they deliver to customers. Bonuses will be determined, in part, by customer feedback, and by a sales professional's adherence to the company values of transparency, integrity, respect and patient-focus.
› Verified 6 days ago
Ms. Katherine Marie Knorr, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3811 Ohara St, Pittsburgh, PA 15213 Phone: 412-235-5445 Fax: 412-235-5446 | |
Krista Mechling, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1010 Delafield Rd, Pittsburgh, PA 15215 Phone: 412-360-6082 | |
Matthew Francis Wilson, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 417 Gettysburg St Ste 200, Pittsburgh, PA 15206 Phone: 412-712-2863 | |
Elizabeth Patterson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 250 Shady Ave, Pittsburgh, PA 15206 Phone: 412-639-1711 | |
Mrs. Judith Lynn Howells, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Pittsburgh Pastoral Institute, 6324 Marchand St., Pittsburgh, PA 15206 Phone: 412-661-1239 | |
Paulette Silver, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 552 N Neville St Apt A, Pittsburgh, PA 15213 Phone: 516-909-9926 | |
Mary Q Browne, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6324 Marchand St, Pittsburgh, PA 15206 Phone: 412-661-1239 |